Synthesis and Pharmacological Characterization of Potent, Selective, and Orally Bioavailable Isoindoline Class Dipeptidyl Peptidase IV Inhibitors

Organic and Medicinal Chemistry Letters
doi 10.1186/2191-2858-1-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Angiotensin-Converting Enzyme and Dipeptidyl Peptidase IV Inhibitors: An Increased Risk of Angioedema

Hypertension
Internal Medicine
2009English

Pyrazolidine Derivatives With Heteroaryl Urea as Dipeptidyl Peptidase IV Inhibitors

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2005English

Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable Γ-Secretase Inhibitor

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2010English

Wound Healing Process and Dipeptidyl Peptidase IV

Medicina fluminensis
2017English

Selective and Orally Bioavailable CHK1 Inhibitors of Some Synthesized Substituted Thieno[2,3-B]pyridine Candidates

International Journal of Pharmacology
Pharmacology
2015English

Design and Synthesis of Novel Potent Non-Peptide and Orally Active Renin Inhibitors

Acta Crystallographica Section A Foundations of Crystallography
1996English

Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lymphocyte-Specific Kinase: Synthesis, Structure-Activity Relationship, and in Vivo Anti-Inflammatory Activity

English

The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Identification of Novel Human Dipeptidyl Peptidase-Iv Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy